238 related articles for article (PubMed ID: 23729673)
1. μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption.
Rouvinen-Lagerström N; Lahti J; Alho H; Kovanen L; Aalto M; Partonen T; Silander K; Sinclair D; Räikkönen K; Eriksson JG; Palotie A; Koskinen S; Saarikoski ST
Alcohol Alcohol; 2013; 48(5):519-25. PubMed ID: 23729673
[TBL] [Abstract][Full Text] [Related]
2. [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].
Gürel ŞC; Ayhan Y; Karaaslan Ç; Akel H; Karaca RÖ; Babaoğlu MÖ; Yaşar Ü; Bozkurt A; Dilbaz N; Uluğ BD; Demir B
Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27370058
[TBL] [Abstract][Full Text] [Related]
3. OPRM1 A118G and serum β-endorphin interact with sex and digit ratio (2D:4D) to influence risk and course of alcohol dependence.
Gegenhuber B; Weinland C; Kornhuber J; Mühle C; Lenz B
Eur Neuropsychopharmacol; 2018 Dec; 28(12):1418-1428. PubMed ID: 30322771
[TBL] [Abstract][Full Text] [Related]
4. Alcohol Consumption in Healthy OPRM1 G Allele Carriers and Its Association with Impulsive Behavior.
Pfeifer P; Sariyar M; Eggermann T; Zerres K; Vernaleken I; Tüscher O; Fehr C
Alcohol Alcohol; 2015 Jul; 50(4):379-84. PubMed ID: 25836994
[TBL] [Abstract][Full Text] [Related]
5. Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population.
Nishizawa D; Han W; Hasegawa J; Ishida T; Numata Y; Sato T; Kawai A; Ikeda K
Neuropsychobiology; 2006; 53(3):137-41. PubMed ID: 16679777
[TBL] [Abstract][Full Text] [Related]
6. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
[TBL] [Abstract][Full Text] [Related]
7. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.
Hartwell EE; Feinn R; Morris PE; Gelernter J; Krystal J; Arias AJ; Hoffman M; Petrakis I; Gueorguieva R; Schacht JP; Oslin D; Anton RF; Kranzler HR
Addiction; 2020 Aug; 115(8):1426-1437. PubMed ID: 31961981
[TBL] [Abstract][Full Text] [Related]
9. Association of the
Sebold M; Garbusow M; Cerci D; Chen K; Sommer C; Huys QJ; Nebe S; Rapp M; Veer IM; Zimmermann US; Smolka MN; Walter H; Heinz A; Friedel E
J Psychopharmacol; 2021 May; 35(5):566-578. PubMed ID: 33726538
[TBL] [Abstract][Full Text] [Related]
10. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis.
Arias A; Feinn R; Kranzler HR
Drug Alcohol Depend; 2006 Jul; 83(3):262-8. PubMed ID: 16387451
[TBL] [Abstract][Full Text] [Related]
11. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
Schwantes-An TH; Zhang J; Chen LS; Hartz SM; Culverhouse RC; Chen X; Coon H; Frank J; Kamens HM; Konte B; Kovanen L; Latvala A; Legrand LN; Maher BS; Melroy WE; Nelson EC; Reid MW; Robinson JD; Shen PH; Yang BZ; Andrews JA; Aveyard P; Beltcheva O; Brown SA; Cannon DS; Cichon S; Corley RP; Dahmen N; Degenhardt L; Foroud T; Gaebel W; Giegling I; Glatt SJ; Grucza RA; Hardin J; Hartmann AM; Heath AC; Herms S; Hodgkinson CA; Hoffmann P; Hops H; Huizinga D; Ising M; Johnson EO; Johnstone E; Kaneva RP; Kendler KS; Kiefer F; Kranzler HR; Krauter KS; Levran O; Lucae S; Lynskey MT; Maier W; Mann K; Martin NG; Mattheisen M; Montgomery GW; Müller-Myhsok B; Murphy MF; Neale MC; Nikolov MA; Nishita D; Nöthen MM; Nurnberger J; Partonen T; Pergadia ML; Reynolds M; Ridinger M; Rose RJ; Rouvinen-Lagerström N; Scherbaum N; Schmäl C; Soyka M; Stallings MC; Steffens M; Treutlein J; Tsuang M; Wall TL; Wodarz N; Yuferov V; Zill P; Bergen AW; Chen J; Cinciripini PM; Edenberg HJ; Ehringer MA; Ferrell RE; Gelernter J; Goldman D; Hewitt JK; Hopfer CJ; Iacono WG; Kaprio J; Kreek MJ; Kremensky IM; Madden PA; McGue M; Munafò MR; Philibert RA; Rietschel M; Roy A; Rujescu D; Saarikoski ST; Swan GE; Todorov AA; Vanyukov MM; Weiss RB; Bierut LJ; Saccone NL
Behav Genet; 2016 Mar; 46(2):151-69. PubMed ID: 26392368
[TBL] [Abstract][Full Text] [Related]
12. Possible association between OPRM1 genetic variance at the 118 locus and alcohol dependence in a large treatment sample: relationship to alcohol dependence symptoms.
Koller G; Zill P; Rujescu D; Ridinger M; Pogarell O; Fehr C; Wodarz N; Bondy B; Soyka M; Preuss UW
Alcohol Clin Exp Res; 2012 Jul; 36(7):1230-6. PubMed ID: 22309038
[TBL] [Abstract][Full Text] [Related]
13. Mu opioid receptor gene variants: lack of association with alcohol dependence.
Bergen AW; Kokoszka J; Peterson R; Long JC; Virkkunen M; Linnoila M; Goldman D
Mol Psychiatry; 1997; 2(6):490-4. PubMed ID: 9399694
[TBL] [Abstract][Full Text] [Related]
14. The role of OPRM1 polymorphism in the etiology of alcoholism.
Samochowiec A; Samochowiec J; Pełka-Wysiecka J; Kucharska-Mazur J; Grochans E; Jabłoński M; Bieńkowski P; Murawiec S; Małecka I; Mak M; Kołodziej Ł; Heitzman J; Grzywacz A
Adv Clin Exp Med; 2019 Feb; 28(2):199-202. PubMed ID: 30085428
[TBL] [Abstract][Full Text] [Related]
15. Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies.
Kong X; Deng H; Gong S; Alston T; Kong Y; Wang J
BMC Med Genet; 2017 Oct; 18(1):120. PubMed ID: 29070014
[TBL] [Abstract][Full Text] [Related]
16. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of ADH1B and OPRM1 alleles predisposing for alcohol consumption are increased in the Hungarian psoriasis population.
Szentkereszty-Kovács Z; Fiatal S; Szegedi A; Kovács D; Janka E; Herszényi K; Holló P; Nikamo P; Ståhle M; Remenyik É; Törőcsik D
Arch Dermatol Res; 2019 Aug; 311(6):435-442. PubMed ID: 31011876
[TBL] [Abstract][Full Text] [Related]
18. Initial evidence of an association between OPRM1 and adolescent alcohol misuse.
Miranda R; Ray L; Justus A; Meyerson LA; Knopik VS; McGeary J; Monti PM
Alcohol Clin Exp Res; 2010 Jan; 34(1):112-22. PubMed ID: 19860800
[TBL] [Abstract][Full Text] [Related]
19. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.
Franke P; Wang T; Nöthen MM; Knapp M; Neidt H; Albrecht S; Jahnes E; Propping P; Maier W
Am J Med Genet; 2001 Jan; 105(1):114-9. PubMed ID: 11424981
[TBL] [Abstract][Full Text] [Related]
20. Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex.
Kleinjan M; Poelen EA; Engels RC; Verhagen M
Addict Biol; 2013 Nov; 18(6):1003-12. PubMed ID: 22260295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
